Fulgent Genetics
Stock Forecast, Prediction & Price Target
Fulgent Genetics Financial Estimates
Fulgent Genetics Revenue Estimates
Fulgent Genetics EBITDA Estimates
Fulgent Genetics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $992.58M N/A | $618.96M -37.64% | $289.21M -53.27% | Avg: $321.74M Low: $309.80M High: $333.67M avg. 11.24% | Avg: $360.52M Low: $351.80M High: $370.94M avg. 12.05% | ||
Net Income
% change YoY
| $507.36M N/A | $143.40M -71.73% | $-167.82M -217.03% | Avg: $-69.56M Low: $-81.27M High: $-75.86M avg. 58.55% | Avg: $-60.09M Low: $-71.07M High: $-66.34M avg. 13.61% | ||
EBITDA
% change YoY
| $677.66M N/A | $190.97M -71.81% | $-46.55M -124.37% | Avg: $97.52M Low: $93.91M High: $101.14M avg. 309.50% | Avg: $109.28M Low: $106.63M High: $112.44M avg. 12.05% | ||
EPS
% change YoY
| $17.13 N/A | $4.76 -72.21% | -$5.63 -218.27% | Avg: -$2.63 Low: -$2.73 High: -$2.55 avg. 53.28% | Avg: -$2.3 Low: -$2.39 High: -$2.23 avg. 12.54% | ||
Operating Expenses
% change YoY
| $101.09M N/A | $185.39M 83.38% | $171.90M -7.27% | Avg: $78.45M Low: $75.54M High: $81.36M avg. -54.36% | Avg: $87.91M Low: $85.78M High: $90.45M avg. 12.05% | ||
FAQ
What is Fulgent Genetics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 36.08% in 2025-2026.
We have gathered data from 2 analysts. Their low estimate is -81.27M, average is -69.56M and high is -75.86M.
What is Fulgent Genetics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 11.65% in 2025-2026.
We have gathered data from 2 analysts. Their low revenue estimate is $309.80M, average is $321.74M and high is $333.67M.
What is Fulgent Genetics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 32.91% in 2025-2026.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$2.73, average is -$2.63 and high is $-2.54.
What is the best performing analyst?
In the last twelve months analysts have been covering Fulgent Genetics stock. The most successful analyst is David Westenberg.